Physician profile
Patrick P Yeung
NPI 1619907672
$1,932.45
in general payments reported to CMS, 2019-2025
10 companies · $55.99 in 2025
The $55.99 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,381 · 2021: $241 · 2022: $65.35 · 2023: $20.13 · 2024: $169 · 2025: $55.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $1,000.00 | 2019 | |
| Conmed Corporation | $333.93 | 2019-2024 | Visiclear, Airseal |
| Hologic Sales and Service, LLC | $177.15 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Ethicon US, LLC | $159.47 | 2021-2022 | |
| Myovant Sciences INC. | $125.00 | 2021 | |
| Baxter Healthcare | $81.21 | 2019 | |
| Sumitomo Pharma America, INC. | $20.13 | 2023 | Myfembree |
| Baudax Bio INC. | $16.99 | 2022 | |
| Elite Orthopedics, LLC | $13.84 | 2025 | |
| Meditrina | $4.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Yeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.